Authorizing Cannabis for Medical Purposes
- Last Reviewed
- 2020-02-29
- Date
- 2015-02-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
- Date
- 2014-10-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
- Date
- 2015-05-14
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-17 An Act to amend the Food and Drugs Act
- Date
- 2014-06-11
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-45: The Cannabis Act
- Date
- 2017-08-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-45: The Cannabis Act
- Date
- 2018-04-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Canada’s lower-risk cannabis use guidelines (LRCUG)
- Date
- 2017-05-26
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Cannabis for Medical Purposes
- Last Reviewed
- 2019-03-03
- Date
- 2010-12-04
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
- Date
- 2012-05-09
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA Recommendations on Vaccine Equity and Intellectual Property
- Date
- 2022-05-13
- Topics
- Ethics and medical professionalism
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
- Date
- 2013-02-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA response to patented medicines regulations consultations
- Date
- 2017-06-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
- Date
- 2017-04-07
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
- Date
- 2018-02-15
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act
(Vanessa's Law)
- Date
- 2015-06-08
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
- Date
- 2012-03-29
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
- Date
- 2014-03-26
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
- Date
- 2012-10-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA submission to the study of Bill C-37
- Date
- 2017-04-06
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs